Regulus Therapeutics — Company Overview, News & Financial Data

Regulus Therapeutics (NASDAQ:RGLS) is a biopharmaceutical company focused on developing innovative treatments for chronic diseases. With a deep commitment to scientific exploration and patient care, Regulus aims to unlock new pathways in disease management through its RNA-targeted therapeutics platform. The company’s projects primarily address conditions with significant unmet medical needs, including kidney diseases, hepatitis C, and cancer. Through rigorous research and clinical trials, Regulus strives to bring forth novel drugs that improve patients’ lives. Among its objectives, the company places a strong emphasis on achieving clinical advancement for its leading drug candidates, ensuring regulatory success, and forging strategic partnerships to enhance drug development and commercialization efforts.